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Introduction
Nanosilver is increasingly used in a wide range of market sectors. 
Annual silver nanoparticle (AgNP) production was estimated at the level 
of 500 tonnes based on 2008 data and more than 200 products containing 
AgNPs are available to the public [1]. Nanosilver antimicrobials, in 
particular, are currently used in a variety of consumer products such 
as throat sprays, antiodor sprays and surface disinfectanct agents that 
carry the potential for inhalation of silver-containing aerosols [2-5].
Humans may also come into contact with nanosilver in the 
occupational setting. During manufacturing, exposure of workers 
to AgNPs is most likely to occur via the respiratory tract [6,7]. Thus, 
absorption from the respiratory tract may represent an important route 
of exposure to AgNPs for workers and consumers.
Toxicity of inhaled AgNPs has been described in a multitude of 
reports and review articles [8]. However several open questions remain 
regarding toxicological and biokinetic aspects, for example the mode 
of action of inhaled AgNPs and the behavior of these nanoparticles 
compared with “conventional” silver aerosols (silver metal and ionic 
silver) [9,10].
Studies in animals have indicated inflammatory changes in the lung 
after pulmonary application of AgNPs even at low doses. Mice treated 
with AgNPs by oropharyngeal aspiration (10 µg/mouse about 350 
µg/kg bw) developed local inflammation with epithelial cell damage 
and activation of lung macrophages [11]. Similarly, Park et al. [12] 
described progressive inflammatory insult in the lung of mice in the 
28-day period following a single i.t. instillation of AgNP (125-500 µg/
kg bw, corresponding to 3-12 µg AgNPs/mouse).
There are also observations indicating that pulmonary toxicity 
of locally applied AgNPs may be accompanied by systemic changes 
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Abstract
The expression profile of genes involved in oxidative stress, metal toxicity, apoptosis/cell cycle, and protein folding 
was investigated in liver and testis of Sprague-Dawley rats at different time intervals after i.t. instillation of AgNP (20 nm, 
50 µg/rat). At 7 days, selective changes in the expression of genes encoding oxidative stress-related enzymes, namely 
Gpx1, SOD, FMO2 and GAPDH were observed in hepatic and testicular tissues. Other genes implicated in oxidative 
stress (Txnrd1, Gss, Gsr), metal toxicity (Mt1), apoptosis/cell cycle (casp3, p53), and protein-folding processes (Hsp70) 
were not modified. Gene expression was modulated by AgNPs in a tissue- and time-dependent manner. In particular, 
SOD was up-regulated in both tissues, but significant Gpx1, FMO2, and GAPDH overexpression was seen in testes 
only. No gene expression changes were seen in both tissues 28 days post-instillation. Unlike AgNPs, pulmonary 
treatment with AgNO3 (7 µg/rat), did not cause gene expression changes in both tissues at both time points studied, 
suggesting that dissimilar mechanisms are implicated in toxicity and/or biokinetics of nanoparticulate and ionic silver. 
The results demonstrate subtle systemic changes involving selected oxidative stress-related genes in the liver 
and testis of animals exposed by pulmonary route to a low dose of AgNPs. These effects were apparently reversible 
as changes were observed at day 7 but not day 28. Recovery could possibly reflect either compensatory mechanism 
contrasting the initial toxicogenomic response to AgNPs or the silver removal from the tested organs. These findings 
may be of toxicological relevance in relation to possible health risks associated with occupational or consumer exposure 
to nanosilver.
resulting from the distribution of silver from the lung to multiple 
secondary organs. For example, a subchronic 90-day inhalation study 
in rats exposed to 18 nm AgNPs (49 to 515 μg/m3) revealed dose-
dependent hepatic alterations with bile-duct hyperplasia, single-
cell hepatocellular necrosis with increased cellular eosinophilia and 
shrunken condensed nuclei in the animals treated with the highest 
AgNP dose [13]. Hepatic inflammatory changes were also described in 
mice treated with AgNPs by oral route [14] or injection [15].
Biokinetic studies in animals given AgNPs by inhalation or lung 
instillation have shown distribution of silver to multiple organs, 
with increased silver levels in liver and testis [12,16-23]. Transfer of 
silver across the blood-testis barrier and predominant localization 
of silver in liver and testis of laboratory animals was also reported 
after administration of AgNPs by oral route [24] or injection [15,25]. 
Excessive testicular levels of silver were still measurable in the animals 
examined 8 weeks after treatment suggesting incomplete tissue 
elimination and some retention of the metal after exposure to AgNPs 
[24]. Crossing of blood-testis barrier by intravenously administered 
AgNPs has also been shown in rabbits at doses which did not affect the 
general health status of the animal, libido, serum testosterone, semen 
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volume and sperm concentration, but caused a dramatic decrease of 
sperm motility and curvilinear velocity [26].
In the present work, toxicogenomic methods were used to determine 
whether gene expression changes are induced in rat liver and testis by 
AgNPs given by lung instillation. The genes examined were selected 
genes related to biochemical end-points that, according to present 
knowledge, are implicated in nanosilver toxicity, namely oxidative 
stress (Gpx1, SOD, Gss, FMO2, Gsr, Txnrd1, GAPDH), metal toxicity 
(Mt1), apoptosis/cell cycle (Casp3, p53), and protein folding (Hsp70). 
Gene expression was examined 7 and 28 days after intratracheal (i.t.) 
instillation of a single dose (50 µg/rat) of AgNPs. The effect of AgNPs 
was compared with the response to AgNO3 used as a control for soluble 
silver ions.
Several reports have indicated oxidative stress as a mechanism 
playing an important role in cytotoxic effects of nanosilver [27,28]. 
AgNPs were shown to induce generation of reactive oxygen species 
and changes in enzyme activities that are associated with antioxidant 
defense systems such as glutathione peroxidase (GPx), reduced 
glutathione (GSH), and superoxide dismutase (SOD). Changes 
involving metallothionein, heat shock protein 70 (Hsp70), glutathione S 
transferase (GST), and p53 have also been documented after nanosilver 
exposure [28-34].
Only few studies have been conducted regarding the effect of 
AgNPs on tissue-specific gene expression. In vitro experiments using 
a human lung epithelial cell line (A549) indicated modulation of 
more than 1000 genes, including members of the metallothionein, 
heat shock protein, and histone families in cells exposed to 12.1 µg/
ml AgNPs (EC20) for 24 hours. At this concentration, AgNPs also 
caused intracellular generation of reactive oxygen species and cell cycle 
alterations with no evidence of apoptosis or necrosis. Considerably 
fewer genes (133 genes) responded to an equivalent amount (1.3 µg/ml) 
of Ag(+) ions [34]. AgNP-induced modulation of oxidative-stress and 
tissue damage related genes was also documented by cell culture studies 
using Caco-2 and M-2 cells [35] as well as by in vivo studies in mice 
and rats. Modulation by AgNPs of inflammation and tissue damage-
related genes was observed in the lung of ICR mice given a single dose 
of 500 µg/kg AgNPs (12-15 µg/mouse) by i.t. instillation [12]. A total 
of 261 genes were up-regulated and 103 genes down-regulated by over 
two fold in the lung 24 hours after treatment. Other toxicogenomic 
studies have been conducted in rats exposed to AgNPs for 12 weeks 
by inhalation at doses corresponding to AgNP concentrations from 
approximately 50 to 380 µg/m3. The results indicated gene expression 
changes in the kidney with 104 genes that were up- or down-regulated 
by more than 1.3-fold. The genes with the most significant change in 
their expression were genes involved in purine metabolism, the B cell 
and T cell receptor signaling pathway, and natural killer cell-mediated 
cytotoxicity. No genes related to apoptosis or cell cycle were modified 
by AgNPs in this study [36].
The field of nanotechnology has grown rapidly over the past few 
years and has even ventured into the field of clinical medicine. Out of 
all kinds of nanoparticles, silver nanoparticles (AgNPs) seem to have 
attracted the most interests in terms of their potential application. 
Indeed, the widespread use of this precious metal in nano-size form 
from household paints to artificial prosthetic devices has imparted 
significant effects on our daily lives. Since the first issue in March 2005, 
this journal has published many quality papers on silver nanoparticles, 
both in basic science as well as in more clinically oriented subjects. In 
this virtual issue, several important papers over these past few years 
have been selected, which will provide readers with further and up-
to-date understanding of synthesis, biological actions, and present 
applications silver nanoparticles in medicine.
Materials and Methods 
Chemicals
All reagents, tissue buffers, chemicals and silver nitrate (AgNO3) 
were purchased from Sigma-Aldrich (Milan, Italy). 
Physicochemical characterization of nanoparticles 
A 1% water suspension of AgNPs (series PARNASOS® NAMA 39 
1103 F01 1%) was supplied by Colorobbia S.p.A. (Vinci, Italy). The 
suspension presented a brown color and the following characteristics: 
1 g/cm3 density, 3 mPa/sec viscosity (25°C), < 0.50 PdI (polydispersity 
index) 6.5 pH, and 20 nm nominal hydrodynamic size diameter 
(supplier data).
Detailed physicochemical characterization of AgNPs was performed 
before their administration to animals. Dynamic light scattering (DLS) 
and scanning transmission electron microscopy (STEM) technique 
with energy dispersion X-ray (EDX) were used to determine shape, size 
distribution, morphology and crystal structure.
A Zetasizer Nano ZS90 (Malvern Instruments, Alfatest-Roma 
Italy) was used to determine the diameter size distribution and zeta 
potential of the AgNPs suspended in deionized water. Aliquots of the 
suspension (250 μl) were transferred to a disposable low volume cuvette 
and after equilibration to 25°C for 2 min. repeated measurements were 
performed using 12 runs of 70 s each. 
AgNPs were imaged by STEM and energy dispersive x-ray 
spectroscopy (EDX) was used for point and line profile analysis. EDX 
was used to determine phase composition of the AgNPs 
STEM with high-angle annular dark-field (HAADF) imaging 
(CAMCOR, University of Oregon, Eugene, OR, USA) was used 
to determine elemental composition, shape, size distribution, and 
morphology of nanoparticles.
High-Resolution TEM (HRTEM) operating in Selected area 
electron diffraction (SAED) mode (a crystallographic experimental 
technique that can be performed inside TEM) was applied to obtain 
information, at small scales, on individual atoms of AgNPs and its 
defects.
Animals and ethics statement 
Adult male Sprague-Dawley rats (12 weeks old) were purchased 
from Charles River Italia (Calco, Italy) and allowed to acclimatize for 
at least 2 weeks before treatment. Throughout the experiment, animals 
were kept in an artificial 12 h light:12 h dark cycle with humidity at 50 
± 10%. Animals were provided rat chow (4RF21 diet) and tap water ad 
libitum. 
All animal experiments were performed according to the guidelines 
of the Maugeri Foundation Animal Care and Use Committee and in 
compliance with the EU Directive 2010/63/EU on the protection 
of animals used for scientific purposes. The study’s objectives and 
procedures were authorized by the Veterinary Health Dept. of the 
Italian Ministry of Health (Rome) - License issued on 01.08.1994, 
ref. n. 90/94, and approved by the Ethic and Welfare Committee for 
Experiments on Animals of Maugeri Foundation. 
Animal treatments
A group of twelve rats was treated with a single intratracheal (i.t.) 
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instillation of AgNPs (50 μg/rat). Separate groups of animals received 
0.1 ml/rat AgNO3 solution intratracheally to administer 7 μg/rat of 
AgNO3 corresponding to 4.4 μg Ag/rat; 10 rats, or 0.1 ml/rat of saline 
(8 rats).
The different applied dosages between AgNPs and AgNO3 rely on 
previous studies [37,38] indicating that the proportion of silver in the 
AgNPs (14 ± 4 nm in diameter) suspension not present as nanoparticles 
was 11% of the total silver concentration and this (ionic form) fraction 
remained stable for several months in suspension. Assuming that the 
AgNPs used in our study released 11% of their silver content as ionic 
silver, it is expected that the animals treated with 50 μg/rat of AgNPs 
received approximately 6 μg/rat of silver ions.
Rats were anesthetized with pentobarbital sodium and i.t. instilled 
with the test materials or saline. Intratracheal administration was 
performed using a Teflon catheter inserted transorally into the trachea 
lumen. To facilitate the procedure, a veterinary fiberoptic otoscope was 
used to view the epiglottis and a speculum to hold the mouth open. 
AgNPs suspension was vortexed immediately before the administration 
to force nanoparticle dispersion and avoid formation of agglomerates.
Gene expression profile examination was conducted 7 or 28 days 
after treatment. Rats were anesthetized by i.p. injection of 35% chloral 
hydrate (100 microl/100 g bw). Liver and testes were removed, placed in 
RNAlater buffer (Sigma) and stored for further analysis.
Nearly monodisperse AgNPs have been prepared in a simple 
oleylamine-liquid paraffin system [16]. It was shown that the formation 
process of AgNPs could be divided into three stages: growth, incubation 
and Oatwald ripening stages. In this method, only three chemicals, 
including silver nitrate, oleylamine and liquid paraffin, are employed 
throughout the whole process. The higher boiling point of 300°C of 
paraffin affords a broader range of reaction temperature and makes it 
possible to effectively control the size of AgNPs by varying the heating 
temperature alone without changing the solvent. Otherwise, the size 
of the colloidal AgNPs could be regulated not only by changing the 
heating temperature, or the ripening time, but also by adjusting the 
ratio of oleylamine to the silver precursor.
Retrotranscription and Semi-quantitative PCR
cDNA was obtained by reverse transcription starting from 4 μg of 
total RNA combined with 1 μl of 50 µM OligodT (Invitrogen™), 1 μl 
of 10 mM dNTPs (Promega Corporation, USA) and DEPC water to a 
final volume of 12 μl. The mixture was preheated at 65°C for 5 min to 
denature secondary structures and then rapidly cooled to 4°C, adding 
4 μl of 5X MMLV Reverse Transcriptase Reaction Buffer (Promega 
Corporation, USA), 2 μl of 0.1 M DTT (Invitrogen™), 0.5 μl of 40 U/
μl RNasin® Plus RNase Inhibitor (Promega Corporation, USA) and 200 
U MMLV Reverse Transcriptase (Promega Corporation, USA. The RT 
mix was incubated at 37°C for 50 min and then stopped by heating 
at 70°C for 15 min. The cDNA stock was stored at -20°C for further 
analysis.
Gpx1, Gss, Gsr, GAPDH, Txnrd1, FMO2, SOD, p53, Casp3, Mt1 and 
Hsp70 were selected as target genes for preliminary semi-quantitative 
analysis [39-41]. β-actin was selected as endogenous gene.
Gene specific primers (Table 1) were designed using the software 
Primer 3 [42,43] and synthesized by InvitrogenTM. 1 μl of c-DNA 
was amplified using 0.75 U of GoTaq DNA Polymerase (Promega 
Corporation, USA), 1 μM solution of specific primers, 5 μl of 5X Green 
GoTaq Reaction buffer, 0.5 μl of 25 mM MgCl2 solution (Promega), 
0.2 mM dNTPs mix in a final volume of 25 μl. PCR reactions were 
conducted in a GeneAmp ® PCR System 2700 thermocycler (Applied 
Biosystem), at the following conditions: 94°C for 5 min followed by 25 
cycles at 94°C for 30 s, 55°C for 30 s, 72°C for 1 min and final extension 
Name Sequence 5' - 3' Tm NCBI AccessionNumber
β-actin
F CTGGTCGTACCACTGGC 55.79 NM_031144.2
R AGCCAGGGCAGTAATCTCC 59.25
glutathione peroxidase 1
(Gpx1)
F TTGAGAATGTCGCGTCC 56.53 NM_030826.3
R CAAGCCCAGATACCAGGA 57.07
glutathione synthetase
(Gss)
F CCAGCGTGCCATAGAGAAC 59.41
NM_012962.1
R GCTGCTCCAGAGCGTGT 58.72
glutathione reductase 
(Gsr)
F CCATGTGGTTACTGCACTTC 56.59 NM_053906.2
R CTGAAGCATCTCATCGCAG 58.17
glyceradehyde-3-phosphate dehydrogenase
(GAPDH)
F GTATGTCGTGGAGTCTACTG 50.33 NM_017008.3
R TTTAGTGGGCCCTCGGC 62.12
thioredoxin reductase 1
(Txnrd1)
F GTCTATGAGAATGCTTACGGG 56.49 NM_031614.2
R CCACGGTCTCTAAGCCAATA 57.85
flavin containing monooxygenase 2 
(FMO2)
F TCACCTGGAGAAGCCAAC 58.36 NM_144737.2
R CGGTGATGGAGAAAAGTG 59.23
superoxide dismutase 
(SOD)
F AAGCATGGCGATGAAGG 58.22 NM_017050.1
R GAGACTCAGACCACATAGGGA 56.72
p53
F CAACACATGACTGAGGTCGT 57 NM_030989.3
R GGGTGAAATATTCTCCATCG 56.9
caspase 3
(Casp3)
F TGCTTACTCTACCGCACCC 58.89 NM_012922.2
R CAACTACCTGATATCAAAGCTGAG 57.33
metallothionein 1(Mt1)
F CTTACACCGTTGCTCCAGAT 57.83 NM_138826.4
R TGAGTTGGTCCGGAAATTAT 57
heat shock 70kD protein
(Hsp70)
F AGTCGGAGAACGTGCAGG 59.98 NM_031971.2
R TGAGACCCTCGTCCTCC 56.94
F = Forward Primer; R= Reverse Primer 
Table 1: Primer used in this work.
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at 72°C for 10 min. Amplification products were resolved on a 1% 
agarose gel in TAE buffer and stained with ethidium bromide, images 
were acquired by the Gel Doc 2000 system and band intensities were 
evaluated using Quantity One software (Bio-Rad).
Real Time PCR and data analysis
Gene specific primers (Table 2) and TaqMan® probes for the genes 
selected by semi-quantitative analysis (Gpx1, GAPDH , FMO2, SOD, 
β-actin) were purchased from Applied Biosystems. cDNA synthesis 
was carried out starting from 4 μg of total RNA using the High-
Capacity cDNA Archive Kit (Applied Biosystem), according to the 
manufacturer’s instructions.
Amplification was performed adding to 1 μl of cDNA, 0.5 μl of 
probe and 6 μl of Taqman Universal Master Mix (Bio-Rad) in a final 
reaction volume of 10 μl. Each sample was then split into two replicate 
of 5 μl. Reactions were conducted in a Bio-Rad CFX ConnectTM 
thermocycler at the following conditions: 95°C for 10 min followed by 
40 cycles at 95°C for 10 s and 60°C for 1 min. Real time amplifications 
were repeated two times for each gene and each sampling time. For 
each target gene (i.e., Gpx1, GAPDH, FMO2, SOD) of each sample, 
β-actin was simultaneously processed as the endogenous control. The 
obtained 2-ΔCt values, where Ct is the Threshold cycle (i.e., the first cycle 
over the background), were recorded and data analysis was performed 
resorting to a Multiple Linear Regression. Time (i.e., 7 and 28 days) and 
organ (i.e., liver and testis) were taken as independent variables, 2-ΔCt as 
the dependent variable.
This citrate-based agent was selected because the weakly bound 
capping agent provides long term stability and is readily displaced by 
various other molecules including thiols, amines, polymers, antibodies, 
and proteins.
Results
Animal body weight
The animals treated with AgNPs or AgNO3 did not differ from 
controls in the rates of their body weight gain over the day-28 post-
treatment period. The average body weight increase was about 40% in 
all groups.
Physicochemical characteristics of silver nanoparticles 
(AgNPs)
Dynamic light scattering (DLS) determination of the AgNP size 
distribution shows a preponderance presence of nanoparticles ranging 
from 10 to 20 nm (evaluation by volume) associated with few dispersed 
particles possessing larger diameter (evaluation by intensity) (Figure 1).
The zeta potential was -15 indicating nanoparticles dispersed 
in water would remain stable during storage. Although there was no 
tendency to agglomerate, the particle sample was vortexed prior to 
measurements.
GENE NCBI Probe ID Amplicon Exon
Gpx1 NM_030826.3 Rn00577994_g1 77 1-2
SOD NM_017050.1 Rn00566938_m1 62 1-2
Fmo2 NM_144737.2 Rn00595179_m1 73 7-8
GAPDH NM_017008.3 Rn01749022_g1 60 1-1
β-actin NM_031144.2 Rn01412977_g1 81 1-2
Table 2: Real-time probes used in this work. 
Figure 1: Size distribution of AgNPs by DLS. Size distribution by intensity and by volume determined using dynamic light scattering (DLS) measurements of 
AgNPs in deionized water.
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Additional techniques were used to better characterize the 
physicochemical properties of the AgNPs tested. 
Quantitative scanning transmission electron microscopy (STEM) 
analysis showed that 25 nm nanoparticles were the predominant entity 
present in the suspension with a relatively narrow size distribution and 
no evidence of aggregation of the AgNPs tested (Figures 2A and 2C).
STEM with high-angle annular dark-field (HAADF) imaging 
showed AgNPs containing pure silver, as indicated by the energy 
dispersive x-ray (EDX) spectrum (Figure 2B). There were no peaks 
of impurities; the other minor elements detected being related to 
water background. Purity represents an important property of the test 
material.
Figure 3 shows the morphologies of AgNPs on atomic scale, as 
determined by High-Resolution Transmission Electron Microscopy 
(HRTEM). The AgNPs were mostly spherical in shape having a smooth 
surface and were well dispersed. HRTEM analysis indicated the 
presence of two populations of nanoparticles, their size being 10-20 
Figure 2: STEM images and EDX spectrum of AgNPs.
A) STEM analysis includes high-angle annular dark-field scanning transmission electron microscopy (HAADF STEM) images. B) A energy dispersive X-ray 
spectrum (EDS). EDS analysis has been performed on the AgNPs indicated that the main composition of sample is Ag only. In particular HAADF STEM images 
show no tendency to aggregate of AgNPs. EDX (left part) were used for point and line profile analyses indicated as [1] in STEM images (right part): comparatively 
background – no nanoparticles (c, bar=200 nm) vs. two different points showing AgNP (a, b, bar=100 nm). C) Selected STEM images of the AgNP sample 
(bar=50 nm).
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nm (the predominant entity) and 40-50 nm, respectively. Presence of 
approximately 20 nm pure silver nanoparticles was also confirmed by 
selected area (electron) diffraction (SAED) pattern analysis (Figure  4 
and Figure 7).
Gene expression profile evaluation
Real-time PCR experiments were performed on testis and liver 
samples to determine possible gene expression changes caused by 
treatments. Preliminary semiquantitative analyses examined Gpx1, Gss, 
Gsr, Txnrd1, FMO2, SOD, p53, Casp3, Mt1, Hsp70, β-actin, and GAPDH 
as candidate target genes, using β-actin as endogenous gene. The gene 
expression pattern observed in liver and testis 7 days after pulmonary 
instillation of AgNPs differed from control. The differentially expressed 
genes were mainly genes involved in oxidative stress, namely Gpx1, 
SOD, FMO2, and GAPDH. Therefore, subsequent quantitative analysis 
using real time PCR was specifically addressed to these genes.
At day 7 post-instillation, the testis of rats treated with AgNPs, 50 µg/
rat (Figure 5) showed up-regulation of all the genes considered (Gpx1, 
SOD, FMO2 and GAPDH). In contrast, at day 28 post-administration, 
testicular gene expression levels were not different in the AgNP-treated 
animals and control (Figure 5A). Similar, although less pronounced, 
changes in the gene expression profile was observed in liver (Figure 5B). 
Genes were up-regulated at day 7 following AgNP instillation while at 
day 28 gene expression was within basal levels.
The animals treated with AgNO3 showed no relevant gene 
expression changes in both the testis and liver tissues at both day 7 and 
day 28 after dosing (Figure 6).
In control animals, the expression of the testicular and hepatic 
genes considered was identical at the day-7 and day-28 observation 
periods (Figures 5 and 6).
The raw data (means reported in Figures 5 and 6) were analyzed 
resorting to generalized linear model (GLM). The p-values of the pair 
wise comparisons are reported in Table 3 for both tissues. The results 
showed that effects of treatments were consistent across the tissue 
samples tested indicating reliable experimental conditions and results 
across the gene expression profile experiments.
In testis, statistical analysis confirmed the AgNP-induced up-
regulation at day 7 and the consequent recovery of the expression at 
day 28 post-treatment. Significant p-values were observed for all the 
comparisons relating to rats examined at day 7, but not for those 
examined at day 28. 
For the liver, AgNP-induced up-regulation was significantly 
confirmed for SOD only suggesting a less pronounced effect of AgNPs 
in liver compared to testis.
For a better comparison of the experiments, in Figure 6, values 
are visualized after normalization with their controls. In other words, 
the data reported in Figure 5 as 2-ΔCt are here expressed as 2-ΔΔCt. This 
normalization consists in subtracting the ΔCt of the control tissues 
from the ΔCt of the tissues of the animals exposed to NPs and ions.
The p-values obtained for all the comparisons between control 
animals examined at day 7 and those examined at day 28 post-
instillation resulted greater than 0.05 confirming that controls at day 7 
and at day 28 can be considered equivalent.
Similarly, pairwise comparisons between animals instilled with 
AgNO3 and controls did not show significant differences at both day 
7 and day 28, confirming that no changes in the hepatic or testicular 
gene expression occurred at both time periods after AgNO3 treatment. 
Discussion
In this study, induction of selected oxidative-stress related genes 
was shown to occur in rat liver and testis after a single treatment with 
AgNPs given by intra-tracheal instillation. The amount of AgNPs 
administered (50 µg/rat) represent a considerably low dose compared 
with other in vivo studies that examined systemic toxicological 
effects of nanosilver. In mice treated with a single dose of AgNPs by 
oropharyngeal aspiration (10 µg/mouse), Bezemer et al. [11] observed 
a strong inflammatory response in the lung, with epithelial cell damage 
and activation of lung macrophages. Similarly, Park et al. [12] described 
marked inflammatory changes in the lung of mice dosed with a 
single i.t. instillation of AgNP (125 to 500 µg/kg bw, corresponding to 
approximately 3-12 µg/mouse). In these studies, the extra-pulmonary 
effects of AgNPs were not examined.
Extra-pulmonary gene expression was up-regulated by the i.t. 
Figure 3: High-Resolution TEM (HRTEM) images. 
HRTEM images simultaneously give information, on atomic scale, in real space 
(in the imaging mode) and reciprocal space (in the diffraction mode). At these 
small scales, individual atoms of AgNP and its defects can be resolved (bar = 
5 nm).
Figure 4: Selected area electron diffraction (SAED) pattern of the AgNPs.
SAED pattern indicates pure AgNP: four diffraction rings and each coincides 
with a diffraction ring of pure Ag (21 nm). 
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instilled AgNPs in a gene type-, organ-, and time-dependent manner. 
AgNPs modulated a group of selected genes that are involved in 
oxidative stress, namely Gpx1, SOD, FMO2 and GAPDH. Other genes 
which are similarly important in oxidative stress processes (Txnrd1, 
Gss, and Gsr) as well as genes that are known to be involved in metal 
toxicity (mt1), apoptosis/cell cycle (casp3, p53), and protein folding 
mechanisms (Hsp70) were not modified by pulmonary treatment with 
AgNPs.
There were differences between liver and testis in the gene 
modulation patterns associated with nanosilver administration. SOD 
was up-regulated by AgNPs in both tissues whereas significant up-
regulation of Gpx1, FMO2, GAPDH occurred in testes only. Induction 
of these genes in hepatic tissue was minimal possibly indicating higher 
susceptibility of testis to gene modulatory effects of AgNPs compared 
with liver. The response to AgNPs was also time-dependent. Gene 
expression changes were observed in the organs of animals examined 
7 days post-administration whereas 28 days after dosing the gene 
expression profiles in liver and testis did not differed from controls.
Figure 5: Expression of Gpx1, GAPDH , FMO2, SOD genes in testis (A) and liver (B) of control and treated animals reported as 2-ΔCt. ΔCt is the difference in Ct 
(Crossing threshold) values for the gene of interest and the endogenous control (housekeeping gene). Rats were treated with a single intratracheal instillation of 
AgNPs or AgNO3 solution and their tissues (testis and liver) were examined after 7 or 28 days.
Figure 6: Relative quantity values of the expression of Gpx1, GAPDH , FMO2, SOD genes in testis and liver, 7 and 28 days after instillation of AgNPs and AgNO3 
solution. The data reported in Figure 5 as 2-ΔCt are here expressed as 2-ΔΔCt. This normalization consists in subtracting the ΔCt of control conditions from those of 
the treated conditions; therefore, all the controls will result 20=1.
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No statistically significant gene expression changes were found in 
hepatic and testicular samples obtained from the animals treated with a 
corresponding dose of AgNO3. 
Physicochemical characterization studies indicated presence of two 
populations of AgNPs, with size ranging from 10 to 20 nm (the majority 
entity) and 40-50 nm (minor item), respectively in the suspension used 
for product instillation. 
Particles were shown to contain no impurities. They were stable 
in suspension, as indicated by STEM analysis, with no tendency to 
agglomerate. 
No attempts were made in our study to determine the release of 
silver from NPs. According to literature data [24] likely referring to 
data reported by Bouwmeester et al. [35], AgNPs suspensions used 
for toxicological studies contain from 6 to 17% of silver in ionic form. 
Moreover, Loeschner et al. [38] in their in vivo AgNP investigation, 
quantified the proportion of silver in the AgNP (14 ± 4 nm) suspension 
not present as nanoparticles. The determination indicates that 11% of 
the total silver concentration was not present as nanoparticles despite 
purification of the AgNP suspension after synthesis, this in agreement 
with a former study from Kittler et al. [37]. Moreover, the Ag ion 
component remained stable over a time period of at least nine months.
The antioxidant genes (Cu/Zn-SOD and gpx1) upregulated by 
AgNPs are genes encoding enzymes that are linked to metabolic 
pathways of considerable toxicological importance. Copper/zinc 
superoxide dismutase (SOD) catalyzes the dismutation of superoxide 
to hydrogen peroxide and molecular oxygen, glutathione peroxidase 
(Gpx) can act as a hydrogen peroxide (H2O2)-removing enzyme. 
Both these enzymes are scavengers exerting a protective role against 
oxidative damage in mammalian cells [44]. FMO and GAPDH genes 
also were upregulated in the liver and testis of rats receiving AgNPs 
by pulmonary route. Flavin-containing monooxygenases (FMO), a 
family of NADPH and FAD-dependent enzymes, are involved not 
only in oxidative metabolism of xenobiotics but also in control of the 
cellular redox potential [45]. In the nematode Caenorhabditis elegans 
model, AgNP-induced up-regulation of the FMO-2 gene was associated 
with oxidative stress [46]. Similarly, glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) was recently identified as a major target 
protein in oxidative stress [47,48].
The observed changes in the expression of oxidative-stress related 
C7 NP7 Ag7 C28 NP28 Ag28
C7
0.143 0.639 0.464 0.461 0.224
6.04E-03 0.994 0.242 0.142 0.207
0.027 0.917 0.069 0.584 0.031
0.035 0.951 0.950 0.849 0.468
NP7
6.62E-05 0.043 0.039 0.019 0.006
2.38E-06 3.68E-03 4.87E-04 3.80E-05 1.08E-04
2.84E-06 0.024 0.924 0.054 0.984
8.70E-06 0.029 0.060 0.012 3.88E-03
Ag7
0.700 1.04E-05 0.735 0.787 0.419
0.095 1.30E-08 0.224 0.120 0.184
0.258 6.06E-08 0.070 0.639 0.029
0.208 1.29E-07 0.993 0.786 0.405
C28
0.868 1.21E-04 0.857 0.906 0.715
0.158 2.19E-07 0.940 0.928 0.950
0.151 5.53E-04 0.015 0.133 0.913
0.820 5.41E-05 0.166 0.809 0.464
NP28
0.903 2.14E-05 0.780 0.951 0.564
0.269 5.46E-08 0.523 0.632 0.856
0.714 2.87E-06 0.118 0.237 0.063
0.767 1.60E-06 0.302 0.610 0.547
Ag28
0.809 1.54E-05 0.879 0.961 0.898
0.196 3.39E-08 0.666 0.766 0.834
0.268 2.24E-05 0.023 0.613 0.425
0.931 2.80E-06 0.213 0.751 0.823
Table 3: p-values of pair wise comparisons. Values of gene expression of liver are reported above the diagonal. The corresponding values for testis are reported below 
the diagonal. The set of four values correspond to the expression of Gpx1, SOD, FMO2 and GAPDH, respectively. C7: animals instilled with control solution and sacrificed 
at day 7; NP7: animals instilled with NP suspension and sacrificed at day 7; Ag7: animals instilled with AgNO3 solution and sacrificed at day 7; C28: animals instilled with 
control solution sacrificed at day 28, NP28: animals instilled with NP suspension and sacrificed at day 28; Ag28: animals instilled with AgNO3 solution and sacrificed at day 
28. (p-value <0.05; p-value <0.01).
 
Figure 7: Microscopic view of silver nanoparticles.
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genes may likely represent a process occurring as part of the initiating 
events in AgNP-induced toxicity, although the mRNA concentration 
changes have been presently emphasized as proxies for abundance of 
corresponding proteins without concurrent measurements of oxidative 
stress (e.g., oxygen species assays, GSH/GSSG quantification) or 
individual protein (Gpx1, FMO2, SOD and GAPDH) expression. 
Studies have indicated a variety of cellular alterations such as protein 
oxidation, lipid peroxidation, inflammatory changes, membrane 
disruption, signaling pathways and mitochondrial dysfunction, DNA 
damage, and apoptosis as common events typically associated with 
AgNP-induced oxidative stress [9,27,39,49]. The up-regulation of 
oxidative stress-related genes encoding SOD and Gpx enzymes may 
be an adaptive mechanism by which hepatic and testicular cells can 
contrast the action of reactive oxygen species generated and initial 
cytotoxic effects caused by AgNPs.
It is unclear from our results if the gene expression changes 
observed after administration of AgNPs reflected a direct action of NPs, 
the action of silver ions released from the nanoparticles or both. It has 
been suggested that the ionic silver released from the particle surface is 
the actual species that accounts for the toxicity of AgNPs [35]. Studies 
have indeed demonstrated a certain release of ions from the surface of 
AgNPs [24,38] that remained stable over several months.
In our experiments, unlike AgNPs, AgNO3 caused no changes in 
hepatic and testicular gene expression, possibly reflecting differences in 
the mechanisms of toxicity and/or pharmacokinetics between AgNPs 
and AgNO3.
With AgNO3 given at low dose levels, much of the absorbed Ag 
ions are expected to precipitate with chloride or phosphate anions 
in biological media or become strongly bound in the form of inert 
complexes with albumin and other macromolecules. In particular, rapid 
neutralization of silver ions likely occurs in the lung of animals instilled 
with AgNO3. Consequently, there would be no passage of biologically 
effective silver from lung to systemic organs and the toxicological 
impact of the irreversibly bound silver would be negligible. 
In our study, the dosage of AgNPs administered to animals was 
considerably low. Therefore, it seems unlikely that the molecular 
changes observed in testis and liver were exclusively dependent on Ag 
ion dissolution from the NPs.
The gene expression changes may have resulted, at least in part, 
from a direct action of AgNPs translocated from lung to liver and 
testis. In principle, there are various mechanisms by which locally 
administered AgNPs may translocate throughout the body and affect at 
distance secondary organs. For example, AgNPs dissolved in body fluid 
may generate systemically distributed Ag ions or AgNPs may interact 
with some proteins and be distributed in the body throughout protein 
metabolism [50].
Although tissue silver concentrations were not measured in our 
study, deposition of silver in liver and testis was documented in animals 
given AgNPs by different administration routes, including inhalation, 
intratracheal instillation, oral gavage, or intraperitoneal injection 
[12,17,18,21,23,51,52]. Comparative studies in rats treated orally with 
ionic silver or nanoparticulate silver indicated almost identical organ 
distribution pattern of the metal, supporting the concept that the metal 
organ deposition is not due to the whole particles being deposited, but 
rather due to the ionic silver contained in the suspension or ionic silver 
that is released from the particle surface [24,38].
However, other experiments in rats treated subcutaneoulsy with a 
large dose of AgNPs (62.8 mg/kg) demonstrated that, even 24 weeks 
after dosing, amounts of silver were present in liver also in the form of 
particles, as shown by TEM analysis [53].
In fact, the respective roles of NPs and ions in AgNP toxicity 
remains a complex issue [54]. The rate of silver ion release from the 
surface of AgNPs in suspension is dependent on the particle size, 
temperature, pH, and oxygen concentration [27]. It is not completely 
clear how dissolved silver ions and the particulate form interact with cell 
components. Gene expression studies in the nematode Caenorhabditis 
elegans showed up-regulation of the FMO-2 gene and oxidative stress 
that were more pronounced with AgNPs than AgNO3 [46] indicating 
that AgNP toxicity cannot be explained solely by the presence of ions 
released into solution by the particles [55].
In recent studies, AgNPs were shown to cause inflammatory 
changes in the lung when given to laboratory animals by respiratory 
route [11,13,19]. Our work confirmed these observations (manuscript 
in preparation). However, the most relevant finding was the occurrence 
of gene expression changes in testis and liver, indicating a possible 
role of these organs as toxicity targets for AgNPs given at low dose 
intratracheally. Testis was apparently more susceptible than liver 
to AgNP-induced changes in gene expression. While SOD was up-
regulated in both tissues, only in testes Gpx1, FMO2, and GAPDH were 
significantly up-regulated 7 days after AgNP instillation. 
Susceptibility of liver and testis to effects of inhaled or ingested silver 
has been indicated by previous reports describing adverse effects such 
as generation of reactive oxygen species, inflammation, morphological 
alterations, changes in enzyme activities, autophagy-related changes, 
cell apoptosis/necrosis and DNA damage to laboratory animals given 
large doses of silver [13,14,18,52,53,55-57]. Rats treated with AgNPs 
(49 to 515 μg/m3) for 13-week showed bile-duct hyperplasia and 
hepatocellular necrosis [13]. Other experiments in rats indicated 
testicular changes after intravenous administration of AgNPs (5 or 10 
mg/kg), with dose-dependent decrease in epididymal sperm count, 
DNA damage in germ cells, and histological changes in seminiferous 
tubules morphology [58]. AgNPs applied to testicular cell preparations 
caused concentration dependent cytotoxicity as indicated by apoptosis, 
necrosis and decreased cell proliferation [59]. 
The results of our study suggest that the hepatic and testicular 
effects induced by nanosilver were reversible. Indeed, over-expression 
of genes encoding antioxidant enzymes was observed in these organs at 
day 7 but not day 28 after i.t. instillation of AgNPs. This would indicate 
recovery from the early gene expression changes caused by AgNPs 
possibly due to compensatory mechanisms or elimination of silver 
from the organs tested. In rats treated by inhalation with elemental 
silver (15 nm) nanoparticles [21], silver was rapidly cleared from the 
lung with only 4% of the initial burden remaining in lung tissue by day 
7 after cessation of exposure. Rapid removal of the metal from lung 
was also observed in rats treated with 50 µg of agglomerate ultrafine 
elemental Ag by i.t. instillation [21]. In rats examined 17 days after 
i.v. administration of AgNPs, Ag concentrations rapidly decreased 
in organs including liver and testes; the peak Ag concentrations was 
measured at day 6 and total elimination of silver was observed by day 
17 [60]. However, other studies in animals treated with high oral doses 
of AgNPs (several milligrams per day) indicated tendency of silver to 
be retained in tissues for long periods, excessive concentrations of the 
metal being measurable in the testis even months after dosing [24,51].
In summary, this study indicated AgNP-induced over-expression 
of four oxidative stress related genes in systemic organs (liver and 
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testis) of animals exposed to a low concentration of Ag-nanoparticles 
by pulmonary route. No AgNP-induced changes occurred in these 
organs regarding other genes similarly linked to mechanisms that are 
important in silver toxicity such as apoptosis and metallothionein 
genes. Unlike AgNPs, ionic silver given as AgNO3 caused no gene 
expression changes in testis and liver.
The induction of antioxidant genes found in 7 days after instillation 
of AgNPs may reflect a first defense response line that is activated in the 
target tissues to contrast the initial AgNP-induced changes in oxidative 
stress pathways.
How toxicologically relevant are the effects caused by inhaled silver 
nanoparticles in the testis and liver is unclear. Imbalance between 
factors promoting oxidative stress and antioxidant capacity has 
generally been described as a condition of toxicological concern which 
can play an important role in pathophysiology of several disease states 
that involve the liver [61] and testis [62]. In particular, a pro-oxidative 
insult inflicted to testis may be of special concern given the inherent 
vulnerability of testis to oxidative stress. Spermatozoa membranes are 
rich of polyunsaturated fatty acids this making them very susceptible to 
oxidative damage. Generation of reactive oxygen species and oxidative 
stress processes have been shown to exert a deleterious impact on 
spermatogenesis and a key role in mechanisms leading to sperm 
function impairment and male infertility [62].
The occurrence of oxidative stress-related changes caused by a low 
dose of AgNPs given via the respiratory tract should also be considered 
with respect to possible health risks associated with occupational 
exposure to AgNPs [63]. The American Conference of Governmental 
Industrial Hygienists [64] recommends a threshold limit value-time 
weighted average (TLV-TWA) of 100 µg/m3 and 10 µg/m3 for metallic 
silver and soluble silver compounds, respectively. These threshold limits 
were derived from classical toxicological studies in which the unique 
physical and chemical properties of silver nanoparticles were not fully 
considered. Indeed, in accordance with the results of our study, a large 
number of literature data, indicate a number of biological and toxic 
effects caused by AgNPs that are peculiar of their nanoscale properties.
More information is needed to determine if the currently established 
ACGIH standards for occupational exposure to silver compounds are 
also adequate to protect workers and consumers from any potential 
harmful exposures to AgNPs.
On the other hand, generalization of our findings requires caution 
for different reasons. First, our study examined the response to AgNPs 
at only two time points post-administration, this precluding a precise 
characterization of the observed gene expression changes with respect 
to time course and recovery. Second, the gene modifications were only 
investigated after one single dose and therefore it is unclear whether 
they reflected a transient non-specific stress response to AgNPs or the 
starting point of progressive changes leading to frank organ toxicity. 
Third, it remains to be established if the AgNP-induced changes were 
specifically dependent on the size of the particles tested. Size can be 
relevant in the cytotoxic effects of AgNPs. Smaller AgNPs can induce 
more oxidative stress, DNA damage and lethality than larger particles 
when compared at mass doses. Furthermore, the high surface area to 
volume ratio of smaller AgNPs may cause enhanced release of toxic Ag+ 
ions from their surface, in comparison with larger AgNPs [27]. 
Further dose-response and long-term exposure studies may 
contribute to determine more precisely the role of AgNPs-induced 
oxidative damage in toxicological effects and health hazards associated 
with nanosilver exposure.
Conclusions
This in vivo research study demonstrates subtle systemic changes 
involving selected oxidative stress-related genes in secondary target 
organs (such as testis and liver) of animals exposed by pulmonary 
route to a low dose of silver nanoparticles (AgNPs, 20 nm diameter). 
The AgNP-induced hepatic and testicular effects were reversible as 
gene expression changes were observed at day 7 but not day 28 after 
instillation. 
The present findings, in accordance with a large number of literature 
data, support the evidence of the capability of AgNPs to cause biological 
and toxic effects that are peculiar of their nanoscale properties, and may 
contribute to provide information needed to determine if the currently 
established ACGIH standards (for occupational exposure to silver 
compounds) are also adequate to protect workers and consumers from 
any potential harmful exposures to AgNPs.
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